Try adjusting your type
14th October, 2009
European Survey on Standards of Care in paediatric oncology centres. J. R. Kowalczyk, M. Samardakiewicz, K. Pritchard-Jones, R. Ladenstein, S. Essiaf, E. Fitzgerald, G. Petrarulo, G. Vassal - EJC , Volume 61, pp 11-19
8th December, 2014
The purpose of this website is to provide good and clear information about the long-term effects of childhood cancer and to refer to the various late-effects outpatient clinics (LATER outpatient clinics) that exist in the Netherlands.
8th September, 2015
Cancer in young people is rare, but it is still a major health issue in Europe. Each year, more than 6,000 young people in Europe die of cancer. There are more than 300,000 European childhood cancer survivors (in 2020, they will be nearly half a million): two-thirds of them have some late side effects of treatment, that are severe and impact on the daily life of half of those affected.
“B-cell” refers to a type of white blood cell that plays a pivotal role in the immune system. B-cells can mature into cells that produce antibodies, specialized proteins that help fight infections, viruses and diseases. They also create immune memory, enabling the immune system to respond more efficiently to future exposures to the same pathogens.
In the realm of immunology, B-cells, also known as B-lymphocytes, hold a significant position. These form an integral part of the white blood cells and play a crucial role in the immune response to foreign substances, such as bacteria and viruses, in our bodies. B-cells majorly contribute to the humoral component of the adaptive immune system by producing antibodies to neutralize pathogens.
The discovery of B-cells traces back to the 1960s with the contributions of several pioneering immunologists. Increased understanding of these cells has led to monumental advancements in health and disease management.
B-cells play a protean role in the immune system. They originate and mature in the bone marrow and then circulate in the peripheral bloodstream and secondary lymphoid tissues. In response to antigens, they generate specific antibodies.
The lifespan of B-cells varies; some immune responses may last for decades, while others could be short-lived. While the molecular mechanism controlling their lifespan is still a topic of research, scientists have found that the growth and development of B-cells undergo several controlled stages marked by various gene expressions.
B-cells serve as the body’s defense mechanism by generating millions of different antibodies, each capable of binding to a unique antigenic determinant. Furthermore, they remember previously encountered pathogens and respond faster and more robustly when these reappear.
When a foreign pathogen enters the body, B-cells spring into action by producing specific antibodies against the intruder, subsequently neutralizing the threat. This process forms the backbone of the humoral immune response.
B-cell activation is a critical step in the immune response as it prompts the production of the appropriate antibodies and memory B-cells. This activation occurs when a B-cell receptor binds to foreign antigens and presents these antigens to T-cells, facilitating a sustained immune response.
B-cells interact and cooperate with other immune cells, primarily T-cells, to provide a comprehensive immune response. This interaction helps in the production of an array of cytokines, which orchestrate the immune response.
A variety of diseases are linked with anomalies in B-cells, such as multiple sclerosis, lupus, and rheumatoid arthritis. Dysregulated B-cell responses could lead to the overproduction of self-reactive antibodies, resulting in autoimmunity.
B-cell lymphomas are types of cancer that originate in B-cells. With numerous subtypes, these are predominantly characterized by the unchecked growth and proliferation of B-cells, leading to swollen lymph nodes and other symptoms.
While B-cells are crucial for a healthy immune system, alterations in their functions can lead to autoimmune diseases. In such scenarios, they produce autoantibodies that mistakenly target the body’s own tissues.
B-cells have taken center stage in cancer research due to their dual role. On one hand, they contribute to tumour progression, and on the other, they can stimulate anti-tumour immunity. Understanding these mechanisms can lead to novel therapeutic interventions.
Recent years have seen significant growth in understanding B-cell biology and this has propelled advancements in targeted B-cell therapies. These come in the form of monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), and chimeric antigen receptor (CAR) T-cells, all of which are redefining cancer treatment paradigms.
There is a growing number of clinical trials investigating the use of B-cell targeting therapies. Many of these therapies are doing exceptionally well, with some already approved for common types of B-cell lymphoma and autoimmune disorders.
B-cells have a profound impact on our health. They not only defend our bodies from foreign pathogens but also serve as invaluable tools for the treatment and potentially even the cure of various diseases. The future of B-cells in therapeutic development seems promising, with researchers relentlessly working to exploit their full potential.
B-cells are unique in their ability to produce antibodies against a virtually limitless array of antigens. They also possess the ability to remember previously encountered antigens leading to quicker and more robust responses upon reinfection.
B-cells are activated when B-cell receptors recognize and bind to foreign antigens, which are then internalized and presented to T-cells, leading to the production of antibodies.
B-cells can both hinder and aid in tumour progression. However, they can also be prime sources of cancer, such as B-cell lymphomas. Furthermore, understanding the roles of B-cells in cancer has led to the development of cutting-edge targeted therapies.
B-cell dysfunctions are associated with a variety of diseases such as lupus, rheumatoid arthritis, multiple sclerosis, and B-cell lymphomas.
The understanding of B-cell biology has led to the development of targeted therapies such as mAbs, ADCs, and CAR T-cells. These hold promise in treating diseases like autoimmune disorders and cancers.
Share it
You might also like
Surviving Triple-Negative Breast Cancer: Hope, Treatment, and Recovery
After her diagnosis of hormone-negative breast cancer, health journalist Patricia Prijatel did what any reporter would do: start investigating the disease, how it occurs, how it's treated, and how to keep it from recurring.
It’s Not About the Bike: My Journey Back to Life
"It's Not About the Bike," co-authored by Lance Armstrong and Sally Jenkins, is a gripping memoir that chronicles Armstrong's journey from a cancer diagnosis with low survival odds to his astonishing comeback and victory in the 1999 Tour de France. This inspiring tale is a testament to the resilience of the human spirit and the power of determination to overcome life's greatest challenges.
The Resilience Factor: 7 Keys to Finding Your Inner Strength and Overcoming Life’s Hurdles
Everyone needs resilience, and now two expert psychologists share seven proven techniques for enhancing our capacity to weather even the cruelest setbacks.
Wherever You Go, There You Are: Mindfulness Meditation in Everyday Life
Its message, rooted in the art of mindfulness, encourages individuals to live fully in the present moment. With gentle yet profound insights, the book teaches us to be fully present in our lives, regardless of our surroundings or situations.
The Truth about Cancer: What You Need to Know about Cancer’s History, Treatment, and Prevention
New in paperback: the controversial bestseller from one of health care's most passionate and outspoken advocates that reveals what we need to know about cancer to protect ourselves, treat ourselves, and even save our lives.
Mind Over Medicine: Scientific Proof That You Can Heal Yourself
New York Times bestseller and beloved guide, revised and updated with up-to-the minute scientific and spiritual insight, teaches readers how to listen to their bodies and assess all areas of their lives--relational, psychological, creative, environmental, professional--to understand what they need for health.
